PubRank

Yoichi Naito

Author PubWeight™ 16.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008 2.32
2 Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer? Int J Clin Oncol 2007 0.95
3 Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis. Breast Cancer Res Treat 2014 0.94
4 Re-challenge chemotherapy for relapsed non-small-cell lung cancer. Lung Cancer 2010 0.90
5 Cabazitaxel for castration-resistant prostate cancer. Lancet 2011 0.84
6 Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis. Breast Cancer Res Treat 2014 0.83
7 Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer. Invest New Drugs 2014 0.82
8 Intrapulmonary metastasis in resected pathologic stage IIIB non-small cell lung cancer: possible contribution of aerogenous metastasis to the favorable outcome. J Thorac Cardiovasc Surg 2007 0.81
9 Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer. Intern Med 2011 0.80
10 First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma. Urology 2013 0.80
11 [A resected case of sclerosing thymoma]. Nihon Kokyuki Gakkai Zasshi 2006 0.79
12 Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors. Expert Opin Pharmacother 2014 0.79
13 Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR. Breast Cancer Res Treat 2014 0.77
14 Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. Anticancer Drugs 2015 0.77
15 The safety of chemotherapy for breast cancer patients with hepatitis C virus infection. J Cancer 2013 0.76
16 Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy. J Cancer Res Clin Oncol 2012 0.76
17 Early prostate cancer--treat or watch? N Engl J Med 2011 0.75
18 Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer. N Engl J Med 2010 0.75
19 Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer. Asia Pac J Clin Oncol 2012 0.75